May 16, 2024

News and Political Commentary

Entrada Therapeutics started at outperform with $22 stock price target at Oppenheimer

1 min read

[Entrada Therapeutics started at outperform with $22 stock price target at Oppenheimer

Tomi Kilgore

2024-01-05 08:39:00

All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator


Read more from original source here…

Leave a Reply

Copyright © All rights reserved. | Newsphere by AF themes.